Synthetic Genetic Regulatory Elements for Stacked Transgene Expression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for controlling gene expression in transgenic cells and organisms face challenges such as gene silencing and limited availability of suitable promoters, particularly when stacking multiple transgenes, due to the activation of silencing mechanisms and the lack of well-characterized promoters providing desired expression patterns.

Innovation Solution

A computational algorithm is used to design synthetic genetic regulatory elements, including promoters and introns, that are similar to naturally occurring sequences but share little extended homology, allowing for precise control of gene expression without requiring knowledge of functional motifs or cis-elements, and are applicable across various species and organisms.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If multiple copies of the same regulatory sequence are used to stack transgenes, then coordinated expression is promoted, but gene silencing mechanisms are activated

Engineering Contradiction:
Improvecoordinated expressionVSAvoidgene silencing
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent divides the regulatory sequence into multiple distinct segments or modules (e.g., promoter, enhancer, terminator elements) that can be independently selected and combined. This segmentation allows creating unique regulatory sequences for each transgene stack member, maintaining coordinated expression through modular design while avoiding silencing by ensuring sequence diversity among stacked transgenes.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent applies different regulatory sequence characteristics to different positions or functions within the expression cassette. Specific local regions (e.g., core promoter vs. upstream enhancer elements) are optimized independently, allowing tailoring of expression patterns while maintaining overall coordination. This local differentiation prevents complete sequence identity across stacked transgenes, reducing silencing risk.

Inventive Principle:
Principle #3Local quality

2Productivity

If the CaMV 35S promoter is used to drive high-level constitutive expression of multiple transgenes, then expression level is improved, but the same promoter causes gene silencing when used more than once

Engineering Contradiction:
Improveexpression levelVSAvoidgene silencing
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent systematically varies key parameters of the promoter sequence while maintaining functional integrity. This includes modifying nucleotide composition, altering spacing between regulatory elements, changing consensus sequence matches, or adjusting promoter length. These parameter changes create promoter variants that retain high-level constitutive expression capability but differ sufficiently in sequence to avoid triggering silencing mechanisms when stacked.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent constructs composite promoters by combining elements from different natural promoters or synthetic regulatory sequences. Rather than using identical CaMV 35S promoters, the invention creates chimeric promoters incorporating functional domains from multiple sources (e.g., Rubisco small subunit promoter elements, other viral promoter elements, or synthetic sequences) that collectively provide high-level constitutive expression with enhanced sequence diversity to prevent silencing.

Inventive Principle:
Principle #40Composite materials

3Manufacturing precision

If well-characterized promoters are used for precise control of gene expression, then expression pattern control is improved, but suitable promoters are few and often already used causing silencing

Engineering Contradiction:
Improveexpression pattern controlVSAvoidpromoter availability
Core Design Contradiction:
Manufacturing precisionVSAdaptability or versatility

Solution Approach 1:

The patent employs computational algorithms and bioinformatics tools to automatically design and optimize regulatory sequences based on desired expression patterns. Rather than relying on a limited library of pre-characterized promoters, the system self-generates custom promoters tailored to specific needs (tissue-specific, inducible, constitutive patterns) by analyzing genomic data, identifying functional elements, and assembling optimized sequences, thereby expanding available options while maintaining precise control.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent develops a universal framework and toolkit for regulatory sequence design that can generate promoters with various expression patterns (constitutive, tissue-specific, inducible) from a single systematic approach. This universal method uses conserved functional domains and modular assembly principles that work across different plant species and expression contexts, providing versatile promoter solutions without requiring separate characterization for each specific case.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS12188028B1Methods for making genetic regulatory elements
Publication Date: 2025.01.07 MONSANTO TECHNOLOGY LLC
  • US12188028B1 patent drawing
  • US12188028B1 patent drawing

AI summary

The present invention provides methods, computer systems and computer-implemented products for making synthetic regulatory elements, and provides polynucleotide's, transgenic cells, and transgenic organisms (including viruses and viral vectors) produced by these methods. The invention thereby provides regulatory sequences to meet various gene expression objectives, including the ability to stack a plurality of heterologous genes for expression in a single cell, while avoiding gene silencing or reduced expression levels.